Your browser doesn't support javascript.
loading
A novel splice-altering TNC variant (c.5247A > T, p.Gly1749Gly) in an Chinese family with autosomal dominant non-syndromic hearing loss.
He, Min; Hu, Miaomiao; Zhang, Qiang; Yao, Kai.
Afiliação
  • He M; Department of Neurology, The First People's Hospital of Wuhu, Chizhu Shandong Road, Jiujiang District, Wuhu, 241000, Anhui Province, China. hm2006255@163.com.
  • Hu M; Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Dian Diagnostics Group Co., Ltd., Hangzhou, 310030, Zhejiang Province, China.
  • Zhang Q; Department of Neurology, The First People's Hospital of Wuhu, Chizhu Shandong Road, Jiujiang District, Wuhu, 241000, Anhui Province, China.
  • Yao K; Department of Neurology, The First People's Hospital of Wuhu, Chizhu Shandong Road, Jiujiang District, Wuhu, 241000, Anhui Province, China.
BMC Med Genomics ; 17(1): 189, 2024 Jul 17.
Article em En | MEDLINE | ID: mdl-39020321
ABSTRACT

BACKGROUND:

This study aims to analyze the pathogenic gene in a Chinese family with non-syndromic hearing loss and identify a novel mutation site in the TNC gene.

METHODS:

A five-generation Chinese family from Anhui Province, presenting with autosomal dominant non-syndromic hearing loss, was recruited for this study. By analyzing the family history, conducting clinical examinations, and performing genetic analysis, we have thoroughly investigated potential pathogenic factors in this family. The peripheral blood samples were obtained from 20 family members, and the pathogenic genes were identified through whole exome sequencing. Subsequently, the mutation of gene locus was confirmed using Sanger sequencing. The conservation of TNC mutation sites was assessed using Clustal Omega software. We utilized functional prediction software including dbscSNV_AdaBoost, dbscSNV_RandomForest, NNSplice, NetGene2, and Mutation Taster to accurately predict the pathogenicity of these mutations. Furthermore, exon deletions were validated through RT-PCR analysis.

RESULTS:

The family exhibited autosomal dominant, progressive, post-lingual, non-syndromic hearing loss. A novel synonymous variant (c.5247A > T, p.Gly1749Gly) in TNC was identified in affected members. This variant is situated at the exon-intron junction boundary towards the end of exon 18. Notably, glycine residue at position 1749 is highly conserved across various species. Bioinformatics analysis indicates that this synonymous mutation leads to the disruption of the 5' end donor splicing site in the 18th intron of the TNC gene. Meanwhile, verification experiments have demonstrated that this synonymous mutation disrupts the splicing process of exon 18, leading to complete exon 18 skipping and direct splicing between exons 17 and 19.

CONCLUSION:

This novel splice-altering variant (c.5247A > T, p.Gly1749Gly) in exon 18 of the TNC gene disrupts normal gene splicing and causes hearing loss among HBD families.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linhagem Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linhagem Idioma: En Ano de publicação: 2024 Tipo de documento: Article